Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
By Peter Leung
In navigating its exit from the European Union, the U.K. will likely stress that the upcoming Unified Patent Court is the product of an international treaty, and is not an EU institution, so that the country can participate in the new patent court, which will cover most of Europe.
The U.K. government Aug. 23 released a position paper on its future relationship with the EU after its “Brexit” from the bloc. The government did not discuss the UPC, but emphasized it is common for parties to international treaties to agree to submit disputes to bodies such as the Court of Justice of the European Union, the highest court in the EU.
The U.K. is supposed to be one of the big players in the UPC, which will be accompanied by a new patent right that covers most of Europe. The U.K.’s vote to leave the EU has raised questions about its continued participation and the future of the UPC.
Prime Minister Theresa May has said that Brexit will end the CJEU’s “direct legal authority” over the U.K. But her government has also agreed to ratify the agreement to start the UPC, which is bound by CJEU decisions.
If the position paper is any indication, the U.K. government will likely argue that the CJEU’s role in the UPC doesn’t impose “direct authority” over the U.K., and instead is akin to a more limited role in ensuring the consistent application of an international treaty, U.K. patent lawyers told Bloomberg BNA.
The U.K.’s relationship with the CJEU is “highly political,” but the public is probably more concerned with the court’s role in issues such as immigration, rather than patent law, Julian Crump, principal and patent attorney at Beresford Crump LLP in London, told Bloomberg BNA.
Voters for the Brexit last year were motivated in part by a promise to regain the nation’s sovereignty from the EU. The CJEU is a particular sore point for Brexit supporters.
However, the U.K. Intellectual Property Office has characterized the UPC as an “international patent court” since it announced in November 2016 that the U.K. will ratify the UPC agreement. The CJEU’s role in the UPC system is also rather limited, Edward Nodder, senior partner of patent litigation at Bristows LLP in London, told Bloomberg BNA.
“It’s important to remember that the appeals court is not the CJEU—the UPC will have its own very experienced appeals court,” he said. Appeals from the UPC will be heard by the UPC’s Court of Appeal under the UPC agreement.
The CJEU’s role is only to interpret EU law relevant to the UPC when it needs to be clarified, Alan Johnson, partner in patent litigation at Bristows in London, told Bloomberg BNA. The court will be asked to review issues such as supplementary protection certificates, which act as patent term extensions to compensate for protection lost to regulatory approval processes, the Biotech Directive, and perhaps some initial jurisdictional questions, Johnson said. “Those are fairly restrictive, and not desperately important topics in many ways,” he said.
The UPC may not be so different from other international treaties to which the U.K. is a party. For example, the U.K. is part of the European Patent system, which allows inventors to file a single patent application examined by the European Patent Office that can later be validated into national patents in different countries.
The U.K. will continue to be part of that system, even after the Brexit. The U.K. has delegated some of its authority, such as the examination process, to the EPO, an international body, Crump said. The U.K.’s participation in the UPC, which involves the CJEU answering questions relating to EU law, doesn’t seem to be philosophically much different from the delegation of authority to the EPO, he said.
The CJEU’s role may be greatest when the court first starts, as there will be more unanswered questions and unforeseen issues.
The need to clarify the law should fall away with time, and the CJEU will have an ever dwindling role in the UPC, Nodder said.
To contact the reporter on this story: Peter Leung in Washington at email@example.com
To contact the editor responsible for this story: Mike Wilczek at firstname.lastname@example.org
Text available at http://src.bna.com/rWS
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)